A potential coronavirus vaccine developed by Oxford University in the U.K. has produced a strong immune response in a large, early-stage human trial, according to newly-released data published Monday in the medical journal, The Lancet. CNBC’s Meg Tirrell reports. Subscribe…
CNBC’s Meg Tirrell reports on Moderna’s phase 1 vaccine results. Jefferies Managing Director Michael Yee discusses with CNBC’s Melissa Lee and the Fast Money traders, Guy Adami, Dan Nathan, Carter Worth and Bonawyn Eisen. For access to live and exclusive…
Former Allergan CEO Brent Saunders joins “Squawk Box” to discuss the race for a Covid-19 vaccine. For more coronavirus live updates: » Subscribe to CNBC TV: » Subscribe to CNBC: » Subscribe to CNBC Classic: Turn to CNBC TV for…
Dr. Scott Gottlieb, member of the boards of Pfizer, Tempus and biotech company Illumina and former FDA commissioner, tells CNBC’s “Squawk Box” he believes the Covid-19 pandemic will end within six months either because there will be widespread access to…
There are three types of Covid-19 tests: genetic, antibody and antigen. More than 630 distinct tests are commercially available or in development, and some major players include Abbott, Roche, Thermo Fisher, LabCorp and the CDC are involved. CNBC explores how…
Dr. Ian Lipkin, Director of the Center for Infection and Immunity at Columbia, joins “Closing Bell” to discuss the coronavirus pandemic.
